Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

RECKITT BENCKISER INC

Home Clinical Trial Sponsors and OrganizationsRECKITT BENCKISER INC

RECKITT BENCKISER INC

2108 S 54TH St Ste 1, Rogers, Arkansas, United States

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

6

0 active

Approvals

3

Total approvals

Agencies

1

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

4

66.7%

Phase 2

1

16.7%

Phase 4

1

16.7%

Trial Status Distribution

Completed

6

100.0%

Clinical Trials

Trials sponsored by this organization (6)

Mucinex® ER 600 mg Bi-layer Tablet Versus Guaifenesin Immediate Release (IR) 200 mg q4h

Jun 201330 participants

Mucinex Exploratory Cold Study

Dec 2009378 participants

Safety and Efficacy Study of Guaifenesin and Pseudoephedrine for Symptomatic Therapy to Treat Acute RTI

Oct 20091,179 participants

Study to Characterize the Pharmacokinetics of 3 Marketed Products Containing 200 mg Guaifenesin in Healthy Volunteers.

Jun 200930 participants

Study to Evaluate the Pharmacokinetics of Mucinex 600 mg Extended-release Bi-layer Tablet in Healthy Volunteers

Jun 200930 participants

Bioequivalence Study Comparing Mucinex Extended-release 600 mg Tablets to Immediate-release Guaifenesin 600 mg in Healthy Volunteers

Jan 200930 participants

Approvals

Approvals by Agency

CANADA

Health Canada

3

Approvals

Recent Approvals

PROFESSIONAL LYSOL BRAND ANTIBACTERIAL ALL PURPOSE CLEANER

PROFESSIONAL LYSOL BRAND DISINFECTANT HEAVY DUTY BATHROOM CLEANER

News

No news articles found

On this page

Overview
Clinical Trials6
Approvals3
News

Back to Organizations